Further, multivariate logistic regression analysis showed that the EGFR mutant, levels of EDAc-MPs at 3rd month after therapy and the ΔPDAp-MPs and ΔPDAc-MPs were independent prognostic predictors in NSCLC patients (Table 8). Here, EGFR is linked to non-small cell lung carcinoma.